Nanjing Medlander Medical Technology Co. Ltd. A688273
▼ NegativeCapitalrelevance
Interim net profit down 42.54% YoY, revenue down 20.02%, operating cash flow negative.

Medlander released its 2026 interim report. Total operating revenue was 193 million yuan, down 20.02% year on year. Net profit attributable to the parent company was 36.7306 million yuan, down 42.54% year on year. Net cash flow from operating activities was negative 9.7186 million yuan, down 133.30% year on year. The company's asset-liability ratio was 15.85%, gross margin was 66.64%, ROE was 2.75%, and diluted earnings per share was 0.38 yuan.
Nanjing Medlander Medical Technology Co. Ltd. AInterim net profit down 42.54% YoY, revenue down 20.02%, operating cash flow negative.